Biologic therapy in psoriasis: navigating the options.
| Autor: | McKay C; Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana, USA., Kondratuk KE; University of South Dakota Sanford School of Medicine, Vermillion, South Dakota. USA., Miller JP; Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA., Stumpf B; Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana, USA., Boh E; Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cutis [Cutis] 2018 Nov; Vol. 102 (5S), pp. 13-17. |
| Abstrakt: | Psoriasis is a T cell-mediated inflammatory disease associated with comorbidities impacting the overall health and quality of life of those affected. This article offers a brief overview of treatment classes available and an approach to choosing biologic treatments based on individual patient characteristics, including disease severity, comorbidities, and ultimate treatment goals. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|